Alto Neuroscience, Inc. ANRO
Set alert
22.19 USD -0.41 -1.81%
At close · Nov 2
22.19 0.00 0.00%
After hours · Nov 2, 4:01 PM ET
21.50 Day range 23.18
11.13 52-week range 36.64
- YTD
- +24.66%
- 1 year
- +56.38%
- Open
- 22.80
- Prev close
- 22.60
- Mkt cap
- 870.78M
- Vol
- 473.28K
- Avg vol
- 563.52K
- EPS
- -2.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.50
- High
- 23.18
- Forward P/E
- -7.78
- Beta
- 1.16
- Short ratio
- 8.92
- Inst. own
- 87.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 31.01
- 200-d avg
- 23.57
- 1y target
- 38.38
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 38.38 +73.0% upside
Now 22.19
- Target (low)
- 26.00
- Target (mean)
- 38.38
- Target (high)
- 55.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy0
- Buy10
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.70286 | -0.89 – -0.60 | -0.52 | -35.2% | 0 | 0.0% | 7 |
| Next quarter | -0.72571 | -0.92 – -0.61 | -0.45 | -61.3% | 0 | 0.0% | 7 |
| Current year | -2.92 | -3.33 – -2.61 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next year | -3.29 | -4.10 – -2.23 | -2.92 | -12.5% | 0 | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Aug 13, 2026 | BTIG | Maintained | Buy | Buy |
| May 18, 2026 | Baird | Maintained | Outperform | Outperform |
| May 14, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 11, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Apr 2, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 2, 2026 | Jones Trading | Maintained | Buy | Buy |
| Apr 2, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Apr 2, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 18, 2026 | Baird | Maintained | Outperform | Outperform |
| Mar 17, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 17, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Feb 17, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 5, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Nov 17, 2025 | BTIG | Initiated | — | Buy |
| Nov 13, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 12, 2025 | Jefferies | Maintained | Buy | Buy |
| Oct 24, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 20, 2025 | Baird | Maintained | Outperform | Outperform |
| Sep 29, 2025 | Chardan Capital | Initiated | — | Buy |
| Aug 18, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2025 | Wedbush | Reiterated | Neutral | Neutral |
| Apr 7, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 16, 2024 | Jones Trading | Initiated | — | Buy |
| Nov 13, 2024 | Stifel | Maintained | Buy | Buy |
| Oct 23, 2024 | Wedbush | Downgrade | Outperform | Neutral |